Ann Lab Med.  2020 Jan;40(1):88-91. 10.3343/alm.2020.40.1.88.

Relationship of Circulating Cytomegalovirus Levels Obtained Through Antigenemia Testing and Quantitative PCR Differs Between Children and Adults

• Choi S
• Kim YJ
• Yoo KH
• Sung KW
• Koo HH
• Kim SJ
• Jang JH
• Kim K
• Jung CW
• Huh HJ
• Kang ES

• KMID: 2457501
• DOI: http://doi.org/10.3343/alm.2020.40.1.88

Abstract

No abstract available.

MeSH Terms

Adult*
Child*
Cytomegalovirus*
Humans
Polymerase Chain Reaction*

Figure

• 

  Fig. 1 Relationship between the CMV antigenemia and CMV DNA Q-PCR results in (A) total subjects, (B) children, and (C) adults as determined by Deming regression analysis. The linear regression curves (solid line) showed significantly different intercepts between children and adults (P=0.02). The dashed line represents the 95% confidence intervals.Abbreviations: CMV, cytomegalovirus; Q-PCR, quantitative PCR; WBC, white blood cell.

Reference

1. Caliendo AM, St George K, Kao SY, Allega J, Tan BH, LaFontaine R, et al. Comparison of quantitative cytomegalovirus (CMV) PCR in plasma and CMV antigenemia assay: clinical utility of the prototype AMPLICOR CMV MONITOR test in transplant recipients. J Clin Microbiol. 2000; 38:2122–2127. PMID: 10834964.

2. Bontant T, Sedlacek P, Balduzzi A, Gaspar B, Cesaro S, Einsele H, et al. Survey of CMV management in pediatric allogeneic HSCT programs, on behalf of the inborn errors, infectious diseases and pediatric diseases working parties of EBMT. Bone Marrow Transplant. 2014; 49:276–279. PMID: 24162611.

3. Boaretti M, Sorrentino A, Zantedeschi C, Forni A, Boschiero L, Fontana R. Quantification of cytomegalovirus DNA by a fully automated real-time PCR for early diagnosis and monitoring of active viral infection in solid organ transplant recipients. J Clin Virol. 2013; 56:124–128. PMID: 23182772.

4. Tahmasebi H, Higgins V, Fung AWS, Truong D, White-Al Habeeb NMA, Adeli K. Pediatric reference intervals for biochemical markers: gaps and challenges, recent national initiatives and future perspectives. EJIFCC. 2017; 28:43–63. PMID: 28439218.

5. Li H, Dummer JS, Estes WR, Meng S, Wright PF, Tang YW. Measurement of human cytomegalovirus loads by quantitative real-time PCR for monitoring clinical intervention in transplant recipients. J Clin Microbiol. 2003; 41:187–191. PMID: 12517846.

6. Kalpoe JS, Kroes AC, de Jong MD, Schinkel J, de Brouwer CS, Beersma MF, et al. Validation of clinical application of cytomegalovirus plasma DNA load measurement and definition of treatment criteria by analysis of correlation to antigen detection. J Clin Microbiol. 2004; 42:1498–1504. PMID: 15070995.

7. Cariani E, Pollara CP, Valloncini B, Perandin F, Bonfanti C, Manca N. Relationship between pp65 antigenemia levels and real-time quantitative DNA PCR for human cytomegalovirus (HCMV) management in immunocompromised patients. BMC Infect Dis. 2007; 7:138. PMID: 18036216.

8. Choi SM, Lee DG, Lim J, Park SH, Choi JH, Yoo JH, et al. Comparison of quantitative cytomegalovirus real-time PCR in whole blood and pp65 antigenemia assay: clinical utility of CMV real-time PCR in hematopoietic stem cell transplant recipients. J Korean Med Sci. 2009; 24:571–578. PMID: 19654935.

9. Peres RM, Costa CR, Andrade PD, Bonon SH, Albuquerque DM, de Oliveira C, et al. Surveillance of active human cytomegalovirus infection in hematopoietic stem cell transplantation (HLA sibling identical donor): search for optimal cutoff value by real-time PCR. BMC Infect Dis. 2010; 10:147. PMID: 20515464.

10. Kwon S, Jung BK, Ko SY, Lee CK, Cho Y. Comparison of quantitation of cytomegalovirus DNA by real-time PCR in whole blood with the cytomegalovirus antigenemia assay. Ann Lab Med. 2015; 35:99–104. PMID: 25553288.